发明名称 Transformed human pluripotent stem cells and associated methods
摘要 The present disclosure provides transformed human pluripotent stem cell (t-hPSC). t-hPSCs are not dependent on Oct4 for renewal and survival, however exhibit a sensitivity to reduced levels of the transcription factor Nanog. Also provided are methods of culturing cells for use in a cell-based screening assay comprising placing one or more transformed human pluripotent stem cells into a receptacle and culturing said stem cells in the receptacle to form a monolayer of stem cells without cell overlap. Methods of screening compounds using t-hPSCs are also described.
申请公布号 US9365821(B2) 申请公布日期 2016.06.14
申请号 US201414329412 申请日期 2014.07.11
申请人 MCMASTER UNIVERSITY 发明人 Bhatia Mickie;Werbowetski-Ogilvie Tamra;Sachlos Eleftherios;Fischer Russell Daniela;Laronde Sarah;Lee JungBok;Szabo Eva;Risueno Ruth
分类号 C12N15/00;C12N5/0735;G01N33/50;C12N5/095 主分类号 C12N15/00
代理机构 Ferris H. Lander, Inc. 代理人 Ferris H. Lander, Inc.
主权项 1. A transformed human pluripotent stem cell (t-hPSC) produced by the variant human embryonic stem cell line deposited with the International Depositary of Canada (IDAC), under Accession No. 220715-01, and designated v-hESC-1, wherein the cell does not require bFGF for maintenance of an undifferentiated state, maintains expression of SSEA3 in the absence of bFGF, co-expresses FGFR1 and IGFR1, has an amplification of at least 0.8 megabase at 20q 11.1-11.2 and grows in a monolayer.
地址 Hamilton, Ontario CA